Profit declines 13.6% to Rs 3,593.2 crore Vs Rs 4,160 crore. Revenue grows 7.7% to Rs 41,473.3 crore Vs Rs 38,506.4 crore. EBITDA increases 10.4% to Rs 22,020.9 crore Vs Rs 19,944.2 crore. Margin expands to 53.1% Vs 51.8%. Exceptional loss at Rs 853.7 crore Vs exceptional gain of Rs 735 crore. Other income falls to Rs 254.7 crore Vs Rs 363.5 crore. Tax expenses jump to Rs 1,744 crore Vs Rs 1,307.8 crore
Profit jumps 10.8% to Rs 1,057 crore Vs Rs 954 crore. Net interest income increases 15.1% to Rs 2,367 crore Vs Rs 2,056 crore. Gross NPA falls to 2.09% Vs 2.11% (QoQ). Net NPA slips to 0.57% Vs 0.6% (QoQ)
Profit zooms 96.1% to Rs 200.6 crore Vs Rs 102.3 crore. Revenue spikes 47.7% to Rs 2,093 crore Vs Rs 1,417.2 crore
Profit plunges 50% to Rs 3,297.5 crore Vs Rs 6,594.2 crore. Revenue grows 2.7% to Rs 13,338.9 crore Vs Rs 12,990.6 crore. Other income falls to Rs 724 crore Vs Rs 1,945.1 crore. Tax expenses stand at Rs 836.6 crore Vs Tax Credit at Rs 1,370.6 crore
The company has executed a Share Purchase Agreement with Khorlochhu Hydro Power (KHPL) for the acquisition of a 40% stake in KHPL for Rs 830 crore. The investment will be made in one or more tranches in the equity stake of KHPL.
The IT services company has completed the acquisition of Blitz 24-893 SE, Germany, through its subsidiary, Infosys Singapore Pte.
The pharma company has launched Elobixibat, a drug to treat chronic constipation, in India. It will market Elobixibat under the brand name BixiBat.
Profit drops 1.9% to Rs 157.4 crore Vs Rs 160.4 crore. Revenue grows 2.2% to Rs 1,296.5 crore Vs Rs 1,269.2 crore EBITDA increases 10% to Rs 235.5 crore Vs Rs 214.3 crore. Margin expands sharply to 18.2% Vs 16.9%. Tata Technologies collaborates with Air India to transform the Air India Aircrafts for delivering travel experience.
Profit spikes 46% to Rs 371.5 crore Vs Rs 254.4 crore. Revenue grows 18% to Rs 1,001.4 crore Vs Rs 848.3 crore
Vikasdhan - Grow your Dhan with Vikasdhan
Disclaimer- not an investment advice, only for educational purpose. To read complete disclaimer - https://www.vikasdhan.com/disclaimer